Financial Instruments - Schedule of available-for-Sale financial instruments (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	$ 209,092	$ 13,769
Unrealized Gain	15
Unrealized Losses	(1,129)	(4)
Fair Value	207,978	13,765
U.S treasury and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	64,162	6,060
Unrealized Losses	(259)	(3)
Fair Value	63,903	6,057
Corporate securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	144,930	7,709
Unrealized Gain	15
Unrealized Losses	(870)	(1)
Fair Value	144,075	$ 7,708
Total cash equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	6,622
Fair Value	6,622
Total cash equivalents | U.S treasury and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	1,001
Fair Value	1,001
Total cash equivalents | Corporate securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	2,831
Fair Value	2,831
Total cash equivalents | Foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	2,790
Fair Value	$ 2,790